Research Proposals on Lasix will be Accepted by HISA Sept. 1

The Horseracing Integrity and Safety Authority called for potential researchers to prepare research proposals on the administration of furosemide, still commonly called Lasix in racing, to Thoroughbred racehorses during the 48-hour period before the start of a race, the organization said in a release Thursday evening. The call for proposals is expected to be released Sept. 1.

As the Authority was created by the Horseracing Integrity and Safety Act (HISA) of 2020, it is mandated by Congress to include at least one study on the use of furosemide. Included in the study is the effect of Lasix on equine health and the integrity of competition while using the medication.

Study conclusions will be used to guide the Authority's Furosemide Advisory Committee (FAC) in its recommendations to the Authority's Board. In evaluating applications, the FAC will pay particular attention to the impact of the proposed work as it applies to racing in North America.

Any questions should be directed to feedback@hisaus.org and titled “HISA research.”